Outcomes and Safety of Tumor Necrosis Factor Inhibitors in Reactive Arthritis: A Nationwide Experience from Iceland.
Bjarni ThorsteinssonArni J GeirssonNiels Steen KroghBjorn Gudbjornssonnull nullPublished in: The Journal of rheumatology (2020)
TNFi are safe and effective in ReA, but treatment tends to be prolonged. Further clinical trials are urgently needed in ReA.